Sign in
Taking peopleNo phase

Triple Sleep-promotion Protocol for Delirium Prevention in Intensive Care Patients

Key facts

Who runs it
Naile ALANKAYA
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
200 people, planned
Started
15 Aug 2026
Expected to end
Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Triple Sleep-Promotion Protocol
Record updated
9 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 18 years or older
  • Admitted to one of the participating intensive care units
  • Expected ICU stay of at least 24 hours
  • Richmond Agitation-Sedation Scale (RASS) score between -3 and +4 at baseline
  • Negative Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) assessment at baseline
  • Able to communicate in Turkish when communication is required for study assessments
  • Written informed consent provided by the patient or, when the patient is unable to provide consent because of their clinical condition, by a first-degree relative

Who cannot take part

  • Dementia or a severe neurological disorder that may interfere with delirium assessment, including stroke or severe head trauma
  • Visual or hearing impairment that prevents implementation of the sleep-promotion intervention
  • Ear infection or tympanic membrane perforation that precludes the use of earplugs
  • Terminal clinical condition
  • Positive CAM-ICU assessment at baseline
  • Delirium related to alcohol or substance withdrawal

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Delirium is a common complication in intensive care units (ICUs) and may be associated with sleep disruption and frequent nighttime disturbances. This randomized controlled trial will evaluate whether a multicomponent nighttime sleep-promotion intervention, called the Triple Sleep-Promotion Protocol, can reduce the occurrence of new-onset delirium in adult ICU patients.

Read full original descriptionShow less

The study is being conducted in four ICUs in Türkiye. Eligible patients who do not have delirium at the beginning of the study will be randomly assigned to either the intervention group or the control group. The intervention includes clustering nighttime nursing care, offering an eye mask and earplugs during protected sleep periods, and reducing avoidable nighttime light and noise whenever clinically feasible. Patients in the control group will receive usual ICU care. Patient safety and clinically necessary care will take priority over all sleep-promotion procedures.

Participants will be followed during their ICU stay for up to five days. Delirium will be assessed twice daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Nighttime sleep quality will also be assessed each morning using the Richards-Campbell Sleep Questionnaire. The primary aim is to determine whether the Triple Sleep-Promotion Protocol reduces the incidence of new-onset delirium compared with usual ICU care.

The 2 groups in the trial

  • Usual ICU CareNo study treatment, for comparison

    Participants assigned to this arm receive usual ICU care according to the routine practices of the participating ICU. No study-specific nighttime care clustering, eye mask, earplugs, or structured reduction of nighttime light and noise is provided as part of the study. All routine clinical monitoring, nursing care, and medically necessary procedures continue according to standard ICU practice.

  • Triple Sleep-Promotion ProtocolTreatment being tested

    Participants assigned to this arm receive the Triple Sleep-Promotion Protocol in addition to usual ICU care. The protocol includes clustering nighttime nursing care, offering an eye mask and earplugs during designated protected sleep periods, and reducing avoidable nighttime light and noise whenever clinically feasible. The intervention is implemented during the nighttime period, approximately 22:00-08:00. Urgent or clinically necessary care, monitoring, and patient safety requirements take priority over all sleep-promotion procedures.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of a Triple Sleep-promotion Protocol on Delirium Incidence in Intensive Care Units: A Multicenter Stratified Randomized Controlled Trial
Record updated
9 September 2026